OBI Pharma, Inc.

OBI Pharma, Inc. financial statements

OBI Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueTWD 58.58MEODHD
Net income−TWD 2.05BEODHD
Cash and equivalentsTWD 759.33MEODHD

OBI Pharma, Inc. financials on 6ix · OBI Pharma, Inc. on 6ix